CA2229287A1 - Regulation de fonctions cellulaires a l'aide d'une expression ectopique de recepteurs non endogenes de signalisation de cellule - Google Patents
Regulation de fonctions cellulaires a l'aide d'une expression ectopique de recepteurs non endogenes de signalisation de cellule Download PDFInfo
- Publication number
- CA2229287A1 CA2229287A1 CA002229287A CA2229287A CA2229287A1 CA 2229287 A1 CA2229287 A1 CA 2229287A1 CA 002229287 A CA002229287 A CA 002229287A CA 2229287 A CA2229287 A CA 2229287A CA 2229287 A1 CA2229287 A1 CA 2229287A1
- Authority
- CA
- Canada
- Prior art keywords
- receptor
- cell
- receptors
- signalling
- signal transduction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La présente invention concerne une cellule in vivo transformée à l'aide d'ADN codant un récepteur de signalisation de cellule, non endogène à celle-ci. Ce récepteur peut activer un processus, endogène à la cellule, de transduction de signal et il peut être activé dans des conditions déterminées, activant ainsi le processus de transduction de signal de manière à réguler une fonction cellulaire commandée par le processus de transduction de signal. Cette invention concerne également un procédé d'expression ectopique d'un récepteur non endogène dans une cellule, ainsi qu'un procédé de régulation d'une fonction cellulaire in vivo, ce dernier consistant à transformer une cellule à l'aide d'ADN codant un récepteur, non endogène à la cellule, de signalisation de cellule, ainsi que décrit ci-dessus, puis, dans des conditions déterminées, à exposer cette cellule à une molécule extracellulaire capable d'activer le récepteur étranger de signalisation de cellule. L'activation du récepteur de signalisation de cellule active le processus de transduction de signal endogène, de manière à réguler une fonction cellulaire commandée par ce processus.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US225495P | 1995-08-14 | 1995-08-14 | |
US60/002,254 | 1995-08-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2229287A1 true CA2229287A1 (fr) | 1997-02-27 |
Family
ID=21699924
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002229287A Abandoned CA2229287A1 (fr) | 1995-08-14 | 1996-08-12 | Regulation de fonctions cellulaires a l'aide d'une expression ectopique de recepteurs non endogenes de signalisation de cellule |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0845045A4 (fr) |
JP (1) | JPH11510704A (fr) |
AU (1) | AU716407B2 (fr) |
CA (1) | CA2229287A1 (fr) |
WO (1) | WO1997007233A1 (fr) |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5166320A (en) * | 1987-04-22 | 1992-11-24 | University Of Connecticut | Carrier system and method for the introduction of genes into mammalian cells |
JP2917998B2 (ja) * | 1988-02-05 | 1999-07-12 | ホワイトヘッド・インスティチュート・フォー・バイオメディカル・リサーチ | 修飾された肝細胞およびその用途 |
US5462856A (en) * | 1990-07-19 | 1995-10-31 | Bunsen Rush Laboratories, Inc. | Methods for identifying chemicals that act as agonists or antagonists for receptors and other proteins involved in signal transduction via pathways that utilize G-proteins |
US5401629A (en) * | 1990-08-07 | 1995-03-28 | The Salk Institute Biotechnology/Industrial Associates, Inc. | Assay methods and compositions useful for measuring the transduction of an intracellular signal |
WO1994010322A1 (fr) * | 1992-10-29 | 1994-05-11 | Board Of Regents, The University Of Texas System | Transfert et ciblage du gene recepteur ldl induit par l'adenovirus |
DE69431106T2 (de) * | 1993-05-10 | 2003-05-08 | The Regents Of The University Of Michigan, Ann Arbor | Gentransfer zu den pankreatischen epithelzellen |
GB9311854D0 (en) * | 1993-06-09 | 1993-07-28 | Medical Res Council | Trh receptor action |
WO1995016772A1 (fr) * | 1993-12-14 | 1995-06-22 | Cornell Research Foundation, Inc. | Systeme d'expression du gene d'adenovirus |
-
1996
- 1996-08-12 AU AU67721/96A patent/AU716407B2/en not_active Ceased
- 1996-08-12 JP JP9509404A patent/JPH11510704A/ja active Pending
- 1996-08-12 CA CA002229287A patent/CA2229287A1/fr not_active Abandoned
- 1996-08-12 WO PCT/US1996/013077 patent/WO1997007233A1/fr not_active Application Discontinuation
- 1996-08-12 EP EP96928135A patent/EP0845045A4/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO1997007233A1 (fr) | 1997-02-27 |
AU6772196A (en) | 1997-03-12 |
EP0845045A4 (fr) | 1999-11-24 |
JPH11510704A (ja) | 1999-09-21 |
AU716407B2 (en) | 2000-02-24 |
EP0845045A1 (fr) | 1998-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69032841T2 (de) | Rekombinante zellen für therapien von infektionen und hyperprolieferative störungen und deren herstellung | |
Frevert et al. | Differential effects of constitutively active phosphatidylinositol 3-kinase on glucose transport, glycogen synthase activity, and DNA synthesis in 3T3-L1 adipocytes | |
US5854067A (en) | Hexokinase inhibitors | |
Kullander et al. | Kinase-dependent and kinase-independent functions of EphA4 receptors in major axon tract formation in vivo | |
RU2279441C2 (ru) | Выделенный растворимый il-20 рецептор (варианты) | |
Ruth | Cyclic GMP-dependent protein kinases: understanding in vivo functions by gene targeting | |
JPH09502083A (ja) | 疾患の治療的処置および予防のためにbcl−2を用いる方法 | |
Mitanchez et al. | Glucose-stimulated genes and prospects of gene therapy for type I diabetes | |
KR19980703454A (ko) | 바이러스 벡터 및 과다증식성 질환, 특히 재발협착증을치료하기 위한 이의 용도 | |
Joshi et al. | Proenkephalin gene expression in C6 rat glioma cells: potentiation of cyclic adenosine 3′, 5′-monophosphate-dependent transcription by glucocorticoids | |
VALTIN et al. | Genetic approaches to the study of the regulation and actions of vasopressin | |
US5891717A (en) | Methods and compositions for inhibiting hexokinase | |
CN109071678A (zh) | 神经生长因子融合蛋白、制备方法及其用途 | |
WO1995013376A1 (fr) | Vecteur de therapie genique pour le traitement de l'insuffisance ou des troubles de la production de globules rouges | |
DE69901536T2 (de) | Behandlung von akuter intermittierender porphyria oder anderen porphyrischen krankheiten | |
AU716407B2 (en) | Regulation of cellular functions by ectopic expression of non-endogenous cell signalling receptors | |
Graham | Ecdysone-controlled expression of transgenes | |
US6518480B1 (en) | Selective target cell activation by expression of a G protein-coupled receptor activated superiorly by synthetic ligand | |
US20030073662A1 (en) | Regulation of cellular functions by ectopic expression of non-endogenous cell signalling receptors | |
WO1997007233A9 (fr) | Regulation de fonctions cellulaires a l'aide d'une expression ectopique de recepteurs non endogenes de signalisation de cellule | |
US6485722B1 (en) | Method for selective engraftment of drug-resistant hematopoietic stem cells | |
WO1995006718A2 (fr) | Procede de suppression de la reponse auto-immune | |
Bogdanovic et al. | Parathyroid hormone inhibits collagen synthesis and the activity of rat Col1a1 transgenes mainly by a cAMP‐mediated pathway in mouse calvariae | |
US20040053836A1 (en) | Method for modulating the production of a selected protein in vivo | |
Wolff et al. | Ectopic expression of thyrotropin releasing hormone (TRH) receptors in liver modulates organ function to regulate blood glucose by TRH |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |